Robert J Zagursky

Title: Innovations of Robert J Zagursky: A Leader in Meningococcal Disease Research

Introduction

Robert J Zagursky, a prolific inventor based in Victor, NY, has established himself as a notable figure in the field of immunology with an impressive portfolio of 21 patents. His contributions are primarily centered around immunogenic compositions aimed at preventing and treating meningococcal disease, particularly focusing on the serogroup B strain.

Latest Patents

Among his latest innovations, Zagursky has developed patent filings related to ORF2086 proteins. These cross-reactive immunogenic proteins can be isolated from Neisseria strains or produced through recombinant methods. His inventions include immunogenic portions of these proteins, biological equivalents, antibodies that can bind specifically to them, and nucleic acid sequences that encode these proteins. The potential applications of these innovations lie in their effectiveness against infections caused by serogroup B of meningococcal disease.

Career Highlights

Zagursky's career has seen him contribute meaningfully to significant pharmaceutical companies, such as Wyeth Holdings Corporation and Serono Genetics Institute. His work in these organizations provided him with the foundation to develop groundbreaking solutions in the immunology space.

Collaborations

Throughout his career, Robert has collaborated with esteemed colleagues including Leah Diane Fletcher and Benjamin J Metcalf. These partnerships have been vital in pushing the boundaries of research and advancing the understanding of meningococcal disease prevention.

Conclusion

Robert J Zagursky's contributions to the field of immunology are marked by his innovative patents and collaborative efforts with other professionals. His ongoing research continues to make strides in addressing meningococcal disease, highlighting his role as a leading inventor in this vital area of medical science.